Sun Pharma to review Q1 FY27 results on July 31
pre-market1 source ↓written by the desknot a recommendation
- 31 July 2026
- to global sales
- 16-18% specialty revenue contribution
- and the company's
- 8.5% domestic market share
Sun Pharmaceutical Industries will announce its Q1 FY27 results on 31 July 2026. Investors are keenly observing the 16-18% specialty revenue contribution to global sales and the company's 8.5% domestic market share. This review is pivotal for assessing growth in the healthcare sector amid ongoing US FDA compliance challenges.
Not investment advice. For informational purposes only.